Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intraarterial, intrathecal, and intravenous use. It enhances the visibility of vascular and tissue structures during radiographic procedures in patients undergoing angiography, computed tomography (CT) imaging, or myelography.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iomeron is an iodinated contrast agent used to improve imaging quality in vascular and soft‑tissue examinations.

- Angiography: provides high‑contrast visualization of blood vessels to aid diagnostic and interventional procedures. - Computed Tomography (CT) imaging: enhances organ and lesion delineation for more accurate radiologic assessment. - Myelography: facilitates clear imaging of the spinal canal and nerve roots during contrast‑enhanced studies.

Iomeron may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Warm sensation or flushing at the injection site. - Metallic or salty taste in the mouth. - Mild nausea or vomiting. - Headache or dizziness. - Transient itching or urticaria. - Temporary mild hypotension.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Acute renal impairment, especially in patients with pre‑existing kidney disease. - Seizures or neurologic disturbances. - Cardiovascular collapse. - Life‑threatening bronchospasm. - Persistent severe hypotension.

When using Iomeron, clinicians should observe specific safety measures.

- Renal function assessment: evaluate kidney status before administration. - Allergy history: confirm no prior iodine or contrast media hypersensitivity. - Dose minimization: use the lowest effective volume for the intended study. - Thyroid monitoring: consider effects on thyroid function in susceptible patients. - Concomitant medications: review drugs that may increase risk of contrast‑induced nephropathy. - Store at ambient temperature: keep in original container, protect from moisture and direct light.

Iomeron can interact with other agents, requiring careful management.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents. - High‑dose iodine supplements or thyroid hormone therapy. - Metformin in patients with impaired renal function. - Radiopharmaceuticals that rely on iodine uptake. - Certain monoclonal antibodies targeting iodine‑binding proteins.

Moderate Interactions (Monitor Closely): - Diuretics that may affect renal clearance. - ACE inhibitors or ARBs that influence kidney perfusion. - Non‑steroidal anti‑inflammatory drugs (NSAIDs). - Anticoagulants that could exacerbate bleeding if contrast‑induced vasodilation occurs.